Visit the News Hub Targeted therapy shrank tumors, shows promise in improving survival Huy Mach The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial.